Pharmaceutical Manufacturing Market Is Expected To Grow At A CAGR Of 11.34% From 2021 To 2028

Pharmaceutical Manufacturing Industry Overview 

The global pharmaceutical manufacturing market size was valued at USD 405.52 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 11.34% from 2021 to 2028. 

The pharmaceutical landscape has undergone a massive transformation with the emergence of new technologies, cost-effective, and more efficient manufacturing approaches. In addition, increasing investment flow in this space has impacted the market growth positively. Manufacturing floor downtime and the production of product waste are reduced by the implementation of robotic technology and Artificial Intelligence (AI). In addition, single-use disposable solutions have gained momentum in this industry and have replaced conventional open transfer manufacturing techniques. Furthermore, the paradigm shift towards integrated, smart, and data-rich paperless operations has resulted in error-free and precise production. Such ongoing developments have propelled drug manufacturing. 

Gather more insights about the market drivers, restrains and growth of the Global Pharmaceutical Manufacturing Market 

Constant progress in the field of personalized medicines has opened up numerous possibilities to target different health maladies and allowed the development of patient-centric models. This progress results in a shift from large batches to smaller batches for the development of complex medicines and autologous patient-centric treatments. This has also encouraged the manufacturers to redesign their supply chain to better align with the patient-centric health care system. 

A rise in drug approvals by the regulatory bodies is expected to fuel the drug manufacturing procedures. For instance, the FDA approved 59 drugs in 2018, 49 drugs in 2019, and 15 drugs up to April 2020. Furthermore, a large number of ongoing clinical trials have created numerous growth opportunities for market growth. 

Mergers & acquisitions in the pharmaceutical industry have increased in the past few years. Most of the well-established companies are consolidating to enhance their market position in the highly competitive environment. Whereas small- to mid-sized pharma companies are being acquired for their innovative capabilities. Moreover, stringent regulations to curb pharmaceutical prices have resulted in a large number of mergers & acquisitions. 

Browse through Grand View Research's Pharmaceuticals Industry Research Reports. 

• Active Pharmaceutical Ingredients Market - The global active pharmaceutical ingredients market size was valued at USD 187.76 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 6.6% from 2021 to 2028. The growth can be attributed to the advancements in active pharmaceutical ingredient (API) manufacturing and the rising prevalence of chronic diseases, such as cardiovascular diseases and cancer.  

• Pharmaceutical Analytical Testing Outsourcing Market - The global pharmaceutical analytical testing outsourcing market size was valued at USD 6.54 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 8.3% over the forecast period. Innovation in the pharmaceutical industry, increasing focus on regulation, safety & quality, rising number of end-users, and pricing benefits of outsourcing are the key factors driving the market. 

Pharmaceutical Manufacturing Market Segmentation 

Grand View Research has segmented the global pharmaceutical manufacturing market on the basis of molecule type, drug development type, formulation, routes of administration, therapy area, prescription, age group, sales channel, and region: 

• Pharmaceutical Manufacturing Molecule Type Outlook (Revenue, USD Billion, 2018 - 2028)
  • Biologics & Biosimilars (Large Molecules)
  • Conventional Drugs (Small Molecules)
• Pharmaceutical Manufacturing Drug Development Type Outlook (Revenue, USD Billion,2018 - 2028)
  • Outsource
  • In-house
• Pharmaceutical Manufacturing Formulation Outlook (Revenue, USD Billion,2018 - 2028)
  • Tablets
  • Capsules
  • Injectable
  • Sprays
  • Suspensions
  • Powders
  • Other Formulations
• Pharmaceutical Manufacturing Route of Administration Outlook (Revenue, USD Billion, 2018 - 2028)
  • Oral
  • Topical
  • Parenteral
  • Inhalations
  • Other Routes of Administration
• Pharmaceutical Manufacturing Therapy Area Outlook (Revenue, USD Billion, 2018 - 2028)
  • Cardiovascular Diseases
  • Pain
  • Diabetes
  • Cancer
  • Respiratory Diseases
  • Other Diseases
• Pharmaceutical Manufacturing Prescription Outlook (Revenue, USD Billion, 2018 - 2028)
  • Prescription Medicines
  • Over-the-counter (OTC) Medicines
• Pharmaceutical Manufacturing Age Group Outlook (Revenue, USD Billion, 2018 - 2028)
  • Children & Adolescents
  • Adults
  • Geriatric
• Pharmaceutical Manufacturing Sales Channel Outlook (Revenue, USD Billion, 2018 - 2028)
  • Retail
  • Non-retail
• Pharmaceutical Manufacturing Regional Outlook (Revenue, USD Billion, 2018 - 2028
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa (MEA) 

Market Share Insights 

• February 2021: WuXi STA; a subsidiary of WuXiAppTec; announced to purchase a Switzerland-based manufacturing facility from Bristol Myers Squibb. 
• February 2020: Merck partnered with a German firm, AMCM, to conduct clinical testing on 3D-printed tablets. 

Key Companies profiled: 

Some prominent players in the global pharmaceutical manufacturing market include 

• Hoffmann-La Roche Ltd.
• Novartis AG
• GlaxoSmithKline plc
• Pfizer, Inc.; Merck & Co., Inc.
• AstraZeneca
• Johnson & Johnson
• Sanofi SA
• Eli Lilly and Company
• AbbVie, Inc.
• Sun Pharmaceutical Industries Ltd.
• Novo Nordisk A/S
• Takeda Pharmaceuticals, Inc.
• Cipla Ltd.
• Bristol Myers Squibb Company
• Gilead Sciences, Inc.

Order a free sample PDF of the Pharmaceutical Manufacturing Market Intelligence Study, published by Grand View Research.